INTUITIVE SURGICAL INC (ISRG) Factsheet

INTUITIVE SURGICAL INC (ISRG) Stock Analysis

Analysis from 10-Q filed 2026-10-21. Data as of Q3 2026.

Overall Grade: F (Concerning)

Grade F (Concerning). ROIC 15.4%. FCF margin 31.1%. Source: 10-Q filed 2026-10-21.

Metric	Value	Context
ROIC	15.4%	Solid returns
FCF Margin	31.1%	Strong cash generation

ROIC 15.4% — Top 25% of sector peers. FCF margin 31.1% — Top 10%.

Explore INTUITIVE SURGICAL INC: Earnings History | Overview

Programmatic access: Available via MCP at mcp.metricduck.com. Tools for ISRG: get_company_overview, get_filing_index (lens: debt_stress, management_outlook, risk_trajectory), get_filing_section, get_metric_history, compare_companies, screen_filing_signals.

---

Profitability: INTUITIVE SURGICAL INC earns 15.4% ROIC, Top 25% in Healthcare

ROIC TTM 15.4%, sector median -8.0%, Top 25%. DuPont: NOPAT margin 23.3% × asset turnover 0.6x. Gross margin 67.2%. Operating margin 28.4%. Source: 10-Q filed 2026-10-21.

Metric	ISRG	Rating	Context
Return on Invested Capital (ROIC)	15.4%	Good	Above sector median of -8.0%
Return on Equity (ROE)	16.9%	Good	Efficient use of shareholder equity
Gross Margin	67.2%	Excellent	Strong pricing power
Operating Margin	28.4%	Excellent	Efficient operations

---

Cash Flow: INTUITIVE SURGICAL INC generates $3.6B FCF at 31.1% margin, positive NaN/8 quarters

FCF TTM $3.6B. FCF margin 31.1%, Top 10%. OCF/Net income 1.4x. Positive FCF in NaN/8 trailing quarters. Source: 10-Q filed 2026-10-21.

Metric	ISRG	Rating	Context
Free Cash Flow Margin	31.1%	Excellent	Excellent cash conversion
Free Cash Flow (TTM)	$3.6B	Good	Positive cash generation
OCF/Net Income	1.4x	Excellent	High earnings quality
FCF Consistency (8Q)	N/A	Warning	Variable cash flow

---

Balance Sheet Analysis for INTUITIVE SURGICAL INC

Source: 10-Q filed 2026-10-21.

---

Valuation: INTUITIVE SURGICAL INC trades at 51.6x earnings

P/E 51.6x. EV/Sales 12.8x. FCF yield 2.4%. Source: 10-Q filed 2026-10-21.

Metric	ISRG	Rating	Context
P/E Ratio	51.6x	Warning	Premium valuation
EV/Sales	12.8x	Warning	Growth premium priced in
FCF Yield	2.4%	Adequate	Lower cash yield

---

Capital Allocation: INTUITIVE SURGICAL INC returns 3.0% shareholder yield, reducing shares 2.3% YoY

Total shareholder yield 3.0% (buyback 3.0%). Share count -2.3% YoY. Capital returned $4.6B TTM. Source: 10-Q filed 2026-10-21.

Metric	ISRG	Rating	Context
Total Shareholder Yield	3.0%	Good	Dividend + buyback yield combined
Buyback Yield	3.0%	Good	Active share repurchases
Share Count Change (YoY)	-2.3%	Good	Net share reduction (accretive)
Total Capital Returned (TTM)	$4.6B	Good	Dividends + buybacks returned to shareholders

---

Sector Rankings

Metric	Value	Percentile	vs Median
Return on Invested Capital (ROIC)	15.4%	Top 25%	-
Free Cash Flow Margin	31.1%	Top 10%	9.5x above
Gross Margin	67.2%	Top 50%	1.1x above
Operating Margin	28.4%	Top 25%	-
Return on Equity (ROE)	16.9%	Top 50%	-
P/E Ratio	51.6x	N/A	-

---

Financial Scorecard

Metric	ISRG	Rating	Sector Context
Return on Invested Capital (ROIC)	15.4%	Good	Top 25% of sector (median: -8.0%)
Free Cash Flow Margin	31.1%	Excellent	Top 10% of sector (median: 3.3%)
Gross Margin	67.2%	Excellent	Top 50% of sector (median: 63.9%)
P/E Ratio (Price-to-Earnings)	51.6x	Warning	High expectations priced in
Free Cash Flow Yield	2.4%	Warning	Growth-focused valuation

---

Frequently Asked Questions

Q: What is INTUITIVE SURGICAL INC's Return on Invested Capital (ROIC)?

INTUITIVE SURGICAL INC (ISRG) has a trailing twelve-month Return on Invested Capital (ROIC) of 15.4%. The 8-quarter median ROIC is 15.1% with a declining trend. Sector median -8.0%. Source: 10-Q filed 2026-10-21.

Q: What is INTUITIVE SURGICAL INC's Free Cash Flow Margin?

INTUITIVE SURGICAL INC (ISRG) has a free cash flow margin of 31.1%, generating $3.6 billion in free cash flow over the trailing twelve months. Source: 10-Q filed 2026-10-21.

Q: What is INTUITIVE SURGICAL INC's P/E ratio and how does it compare to peers?

INTUITIVE SURGICAL INC (ISRG) trades at a P/E ratio of 51.6x, which is above the sector median of N/A. EV/Sales 12.8x. FCF yield 2.4%. Source: 10-Q filed 2026-10-21.

Q: What is INTUITIVE SURGICAL INC's revenue and earnings growth?

INTUITIVE SURGICAL INC (ISRG) grew revenue by 20.5% year-over-year. EPS +9.6% YoY. Source: 10-Q filed 2026-10-21.

Q: Is INTUITIVE SURGICAL INC buying back stock?

INTUITIVE SURGICAL INC (ISRG) repurchased $4.6 billion of stock over the trailing twelve months. This represents a buyback yield of 3.0%. Share count -2.3% YoY. Source: 10-Q filed 2026-10-21.

Q: How does INTUITIVE SURGICAL INC compare to competitors in Healthcare?

Compared to other companies in Healthcare, INTUITIVE SURGICAL INC (ISRG) shows: ROIC 15.4%, sector median -8.0% (Top 25%). FCF margin 31.1%, sector median 3.3% (Top 10%). Gross margin 67.2%, 3.3pp above sector median. These rankings are based on MetricDuck's analysis of all Healthcare companies with available SEC filings.

Q: What warning signs should I watch for with INTUITIVE SURGICAL INC?

No quantitative warning flags fired for INTUITIVE SURGICAL INC (ISRG) on margin trend, FCF trend, ROIC trend, or leverage thresholds. Source: 10-Q filed 2026-10-21.

---

Data Source: Data sourced from 10-Q filed 2026-10-21. TTM metrics as of Q3 2026.

Methodology: Financial metrics calculated from SEC 10-K and 10-Q filings using standardized formulas. Sector comparisons use peer group based on SIC code.

Scope: This analysis covers SEC filing fundamentals — profitability, cash flow, balance sheet, and valuation metrics. For analyst estimates and price targets, consult sell-side research.

This analysis is for informational purposes only and does not constitute investment advice.